{"disease":{"id":"pancreatic-ductal-adenocarcinoma","name":"pancreatic ductal adenocarcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07117045","title":"Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":400000,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT04970056","title":"Pancreatic Cancer Early Detection Consortium","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Arbor Research Collaborative for Health","has_results":false},{"nct_id":"NCT07243262","title":"Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)","phase":"","overall_status":"RECRUITING","enrollment_count":6079,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT06344299","title":"Predictors for Low Rates of Surgical Resection in Elderly Patients With Resectable Pancreatic Ductal Adenocarcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":5302,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT04802993","title":"Survival Among Patients With Pancreatic Cancer Depending on Surgical Resection Rate","phase":"","overall_status":"COMPLETED","enrollment_count":5123,"lead_sponsor_name":"Linkoeping University","has_results":false},{"nct_id":"NCT06151223","title":"A Prospective Registry for Patients at High-Risk for Pancreatic Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06638866","title":"AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT06122896","title":"Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT04291651","title":"UCSF PANC Cyst Registry","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT04449406","title":"Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3500,"lead_sponsor_name":"Queen Mary University of London","has_results":false},{"nct_id":"NCT05845801","title":"Prospective Registry of Young-Adult Patients Diagnosed With Pancreatic Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Azienda Ospedaliera Universitaria Integrata Verona","has_results":false},{"nct_id":"NCT06041009","title":"Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations","phase":"","overall_status":"RECRUITING","enrollment_count":2100,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false},{"nct_id":"NCT06388967","title":"Pancreatic Cancer Detection Consortium","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT04605237","title":"Pancreatic Cancer Recurrence in the Netherlands","phase":"","overall_status":"UNKNOWN","enrollment_count":1750,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT04596865","title":"Recurrence After Whipple's (RAW) Study","phase":"","overall_status":"COMPLETED","enrollment_count":1484,"lead_sponsor_name":"University Hospital Plymouth NHS Trust","has_results":false},{"nct_id":"NCT03693378","title":"A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups","phase":"","overall_status":"COMPLETED","enrollment_count":1349,"lead_sponsor_name":"Immunovia, Inc.","has_results":false},{"nct_id":"NCT07516392","title":"Study of a Polygenic Risk Score to Predict the Risk of Pancreatic Ductal Adenocarcinoma","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1140,"lead_sponsor_name":"Catholic University of the Sacred Heart","has_results":false},{"nct_id":"NCT06445062","title":"Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":1130,"lead_sponsor_name":"Revolution Medicines, Inc.","has_results":false},{"nct_id":"NCT06947382","title":"Clinical Validation of Immunovia Next-Generation Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":1066,"lead_sponsor_name":"Immunovia, Inc.","has_results":false},{"nct_id":"NCT07224750","title":"A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT06989437","title":"A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":982,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT06131840","title":"A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":914,"lead_sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","has_results":false},{"nct_id":"NCT02757859","title":"High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":845,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","has_results":false},{"nct_id":"NCT05379985","title":"Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":754,"lead_sponsor_name":"Revolution Medicines, Inc.","has_results":false},{"nct_id":"NCT06330441","title":"Pancreatic Cancer Screening in a Population at High Risk","phase":"NA","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"Masaryk Memorial Cancer Institute","has_results":false},{"nct_id":"NCT03138213","title":"Comparing Total Laparoscopic Versus Open Pancreaticoduodenectomy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":656,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT04622423","title":"Advanced Therapies for Liver Metastases","phase":"","overall_status":"RECRUITING","enrollment_count":625,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT06608927","title":"Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":610,"lead_sponsor_name":"Arcus Biosciences, Inc.","has_results":false},{"nct_id":"NCT06040541","title":"Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":604,"lead_sponsor_name":"Revolution Medicines, Inc.","has_results":false},{"nct_id":"NCT05254171","title":"Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Panbela Therapeutics, Inc.","has_results":false},{"nct_id":"NCT07445295","title":"Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":558,"lead_sponsor_name":"Chipscreen Biosciences, Ltd.","has_results":false},{"nct_id":"NCT01013649","title":"Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":546,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT04935359","title":"Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":511,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT07241676","title":"Early Recurrence After Surgery for Pancreatic Cancer","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":500,"lead_sponsor_name":"Azienda Ospedaliera di Padova","has_results":false},{"nct_id":"NCT04793633","title":"Evaluating LINFU™: A Noninvasive Method for Collecting Pancreatic Cells for the Early Detection of Pancreatic Cancer","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":500,"lead_sponsor_name":"Adenocyte, LLC","has_results":false},{"nct_id":"NCT07252232","title":"Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Revolution Medicines, Inc.","has_results":false},{"nct_id":"NCT06276803","title":"The LINFU® U.S. Registry for the in the General Population Without Risk Factors","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Adenocyte, LLC","has_results":false},{"nct_id":"NCT07076121","title":"A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":470,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT06079346","title":"A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":455,"lead_sponsor_name":"Oncotelic Inc.","has_results":false},{"nct_id":"NCT06549725","title":"Clinical Performance of Medical Device Software \"Lipidica 1.0\" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening","phase":"NA","overall_status":"RECRUITING","enrollment_count":419,"lead_sponsor_name":"Lipidica, a.s.","has_results":false},{"nct_id":"NCT05149326","title":"KN046 in Subjects With Advanced Pancreatic Ductal Adenocarcinoma.","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":408,"lead_sponsor_name":"Jiangsu Alphamab Biopharmaceuticals Co., Ltd","has_results":false},{"nct_id":"NCT07262957","title":"Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT05314998","title":"Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":394,"lead_sponsor_name":"John Neoptolemos","has_results":false},{"nct_id":"NCT07483554","title":"IBI343 in Combination Therapy for Advanced Malignant Solid Tumors","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":389,"lead_sponsor_name":"Innovent Biologics (Suzhou) Co. Ltd.","has_results":false},{"nct_id":"NCT07224802","title":"Forecasting Occult liveR Metastasis Using an Exosomal Signature for Intelligent Guided Hepatic Targeting","phase":"","overall_status":"COMPLETED","enrollment_count":372,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT07094204","title":"A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":364,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT06958224","title":"Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":360,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT07104864","title":"Early Detection of PDAC in Patients With Chronic Pancreatitis","phase":"","overall_status":"COMPLETED","enrollment_count":359,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT06958328","title":"Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":356,"lead_sponsor_name":"NRG Oncology","has_results":false},{"nct_id":"NCT03317886","title":"Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":354,"lead_sponsor_name":"Wakayama Medical University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}